The price-to-earnings ratio for Novartis AG ADR (NYSE: NVS) is above average at 18.78x. The 36-month beta value for NVS is also noteworthy at 0.59. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 9 rating it as “hold,” and 2 rating it as “sell.”
The public float for NVS is 1.90B, and at present, short sellers hold a 0.20% of that float. The average trading volume of NVS on June 26, 2025 was 1.88M shares.
NVS) stock’s latest price update
Novartis AG ADR (NYSE: NVS) has seen a rise in its stock price by 1.68 in relation to its previous close of 118.0. However, the company has experienced a 3.47% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-26 that ProFound to receive $25M in upfront and near-term milestone payments with a potential value from downstream milestones of $750M per target
NVS’s Market Performance
Novartis AG ADR (NVS) has seen a 3.47% rise in stock performance for the week, with a 5.98% gain in the past month and a 8.93% surge in the past quarter. The volatility ratio for the week is 1.09%, and the volatility levels for the past 30 days are at 1.04% for NVS. The simple moving average for the past 20 days is 2.15% for NVS’s stock, with a 9.99% simple moving average for the past 200 days.
NVS Trading at 5.63% from the 50-Day Moving Average
After a stumble in the market that brought NVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.78% of loss for the given period.
Stock Fundamentals for NVS
Current profitability levels for the company are sitting at:
- 0.3 for the present operating margin
- 0.76 for the gross margin
The net margin for Novartis AG ADR stands at 0.24. The total capital return value is set at 0.23. Equity return is now at value 32.95, with 13.24 for asset returns.
Based on Novartis AG ADR (NVS), the company’s capital structure generated 0.45 points at debt to capital in total, while cash flow to debt ratio is standing at 0.61. The debt to equity ratio resting at 0.81. The interest coverage ratio of the stock is 20.17.
Currently, EBITDA for the company is 20.71 billion with net debt to EBITDA at 1.11. When we switch over and look at the enterprise to sales, we see a ratio of 4.74. The receivables turnover for the company is 6.1for trailing twelve months and the total asset turnover is 0.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.79.
Conclusion
In summary, Novartis AG ADR (NVS) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
